Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ADH1B | P00325 | 1/20 | 0.48 |
| ▸ | ADH1C | P00326 | 1/20 | 0.48 |
| ▸ | ADH1A | P07327 | 1/20 | 0.48 |
| ▸ | ADH4 | P08319 | 1/20 | 0.48 |
| ▸ | ADH7 | P40394 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1794577 | 1.00 | — | — | |
| SCHEMBL1090322 | 1.00 | ALOX15 (0.56) | ALOX15EPHX1TSHRALDH1A1THRB | |
| SCHEMBL19838215 | 1.00 | ALOX15 (0.56) | ALOX15EPHX1TSHRALDH1A1THRB | |
| SCHEMBL18343676 | 1.00 | ALOX15 (0.56) | ALOX15EPHX1TSHRALDH1A1THRB | |
| SCHEMBL1088479 | 1.00 | ALOX15 (0.56) | ALOX15EPHX1TSHRALDH1A1THRB | |
| SCHEMBL2722803 | 1.00 | ALOX15 (0.56) | ALOX15EPHX1TSHRALDH1A1THRB | |
| SCHEMBL2722279 | 1.00 | ALOX15 (0.56) | ALOX15EPHX1TSHRALDH1A1THRB | |
| SCHEMBL1090002 | 1.00 | ALOX15 (0.56) | ALOX15EPHX1TSHRALDH1A1THRB | |
| SCHEMBL1088995 | 1.00 | ALOX15 (0.56) | ALOX15EPHX1TSHRALDH1A1THRB | |
| SCHEMBL2723551 | 1.00 | ALOX15 (0.56) | ALOX15EPHX1TSHRALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116390938-A | Exendin-4 analogues | TXP制药股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| US-20140339137-A1 | METHODS FOR REMOVING METALS AND CATIONS THEREOF FROM OIL-BASED FLUIDS | BAKER HUGHES INCORPORATED (US) | 2014-11-20 | — | — | US | claimed |
| US-20140147960-A1 | IMPROVED PHOTOVOLTAIC DEVICE WITH SOLUTION-PROCESSED CHALCOGENIDE ABSORBER LAYER | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2014-05-29 | — | — | US | claimed |
| US-20140144508-A1 | PHOTOVOLTAIC DEVICE WITH SOLUTION-PROCESSED CHALCOGENIDE ABSORBER LAYER | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2014-05-29 | — | — | US | claimed |
| WO-2014070716-A1 | PROCESS FOR REMOVAL OF ZINC, IRON AND NICKEL FROM SPENT COMPLETION BRINES AND PRODUCED WATER | BAKER HUGHES INCORPORATED (US) | 2014-05-08 | — | — | WO | claimed |
| US-20140121138-A1 | PROCESS FOR REMOVAL OF ZINC, IRON AND NICKEL FROM SPENT COMPLETION BRINES AND PRODUCED WATER | BAKER HUGHES INCORPORATED (US) | 2014-05-01 | — | — | US | claimed |
| US-8613973-B2 | Photovoltaic device with solution-processed chalcogenide absorber layer | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2013-12-24 | — | — | US | claimed |
| CN-102791134-A | Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions | PERKINELMER INC | 2012-11-21 | — | — | CN | claimed |
| US-8153625-B2 | Nitrogen-containing heterocyclic compounds and medicinal use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2012-04-10 | — | — | US | claimed |
| CN-101918027-A | Semi-synthetic GLP-1 peptide-Fc fusion constructs, methods and uses | CENTOCOR INC | 2010-12-15 | — | — | CN | claimed |
| US-20090014017-A1 | Smoker's requisite | ENSLIN GEORGE FREDERICK | 2009-01-15 | — | — | US | claimed |
| US-7341917-B2 | Solution deposition of chalcogenide films containing transition metals | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2008-03-11 | — | — | US | claimed |
| US-20050158909-A1 | Solution deposition of chalcogenide films containing transition metals | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2005-07-21 | — | — | US | claimed |
| US-6894205-B2 | Assay for toxin induced neuronal degeneration and viability in C. elegans | VANDERBILT UNIVERSITY (US) | 2005-05-17 | — | — | US | claimed |
| US-20040112395-A1 | Smoker's requisite | ENSLIN GEORGE FREDERICK (ZA) | 2004-06-17 | — | — | US | claimed |
| EP-1411783-A2 | A SMOKER'S REQUISITE | Enslin, George Frederick (ZA) | 2004-04-28 | — | — | EP | claimed |
| US-20030153476-A1 | Etching Liquid for thermoplastic polyimide resin | TORAY ENGINEERING COMPANY, LIMITED (JP) | 2003-08-14 | — | — | US | claimed |
| US-20030023994-A1 | Assay for toxin induced neuronal degeneration and viability in C. elegans | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-01-30 | — | — | US | claimed |
| WO-2003001197-A1 | ASSAY FOR TOXIN INDUCED NEURONAL DEGENERATION AND VIABILITY IN C. ELEGANS | VANDERBILT UNIVERSITY (US) | 2003-01-03 | — | — | WO | claimed |
| WO-2002080708-A2 | A SMOKER'S REQUISITE | ENSLIN GEORGE FREDERICK (ZA) | 2002-10-17 | — | — | WO | claimed |